Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
Screening of large collection of compounds for anti-human parainfluenza virus type-2 activity and evaluation of hit compounds
University of Skövde, School of Bioscience.
2017 (English)Independent thesis Advanced level (degree of Master (One Year)), 20 credits / 30 HE creditsStudent thesis
Abstract [en]

Human parainfluenza virus type-2 (HPIV-2) is a highly contagious respiratory pathogen that can cause severe respiratory disease known as laryngotracheobronchitis or croup-like disease in children. No specific vaccine or an antiviral drug is currently approved for treatment of HPIV-2 infections. In this project, a library of 14400 diverse compounds had been screened for anti-HPIV-2 activities in cultures of African green monkey kidney cells. All compounds that inhibited the virus induced syncytium-forming activity in these cells were considered as hit compounds. Three hit compounds showed moderate anti-HPIV-2 activity characterized by the IC50 values of 20 µM and selectivity indices of approximately 5. This suggests that the antiviral activity of these compounds was due to targeting activities of cellular rather than viral components. Another hit compound, referred to as compound 5, showed anti-HPIV-2 activity that was manifested as a reduction of area of the virus-induced plaques in cells at not cytotoxic concentrations. Interestingly, this compound did not inhibit initial infection nor the virus production in infected cells as revealed by the time-of-addition assay. Moreover, it showed no direct the virus-inactivating (virucidal activity) against HPIV-2 particles. However, relatively short pre-treatment (4 hours) of the cells with compound 5 prior to the virus infection was sufficient for its plaque size-reducing activity suggesting that anti-HPIV-2 activity of compound 5 was due to targeting activities of cellular rather than viral components. Further studies are needed to elucidate the anti-HPIV-2 mechanism of activity of hit compounds identified in the present study.

Place, publisher, year, edition, pages
2017. , 32 p.
Keyword [en]
Screening, Virucidal activity, Selective index, Cytopathic effect
National Category
Other Medical Sciences Microbiology Microbiology in the medical area
Identifiers
URN: urn:nbn:se:his:diva-14385OAI: oai:DiVA.org:his-14385DiVA: diva2:1155759
Subject / course
Molecular Biology
Educational program
Infection Biology - Master’s Programme
Supervisors
Examiners
Available from: 2017-11-10 Created: 2017-11-09 Last updated: 2017-11-10Bibliographically approved

Open Access in DiVA

vijeta rai(2049 kB)4 downloads
File information
File name FULLTEXT01.pdfFile size 2049 kBChecksum SHA-512
e749f3aaa63c0a69962be84dd630364a820bb0a01a837e6674b9e4b447734f0b09e702fd32222ec5a644940a26e757c58382fc45142424cbdb8238c58b4f2ee3
Type fulltextMimetype application/pdf

Search in DiVA

By author/editor
Rai, Vijeta
By organisation
School of Bioscience
Other Medical SciencesMicrobiologyMicrobiology in the medical area

Search outside of DiVA

GoogleGoogle Scholar
Total: 4 downloads
The number of downloads is the sum of all downloads of full texts. It may include eg previous versions that are now no longer available

urn-nbn

Altmetric score

urn-nbn
Total: 15 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf